Related Experiment Video
Updated: Aug 15, 2026
08:34
OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy
Published on: February 5, 2020
Site-specific polymer modification of therapeutic proteins
1Gryphon Therapeutics, South San Francisco, CA 94080, USA. gkochendoerfer@fibrogen.com
Current Opinion in Chemical Biology
|October 20, 2005
Summary
Chemoselective ligation enables site-specific protein modification with polymers, controlling conjugate structure for optimized drug properties. This technology yields new erythropoietic agents and HIV fusion inhibitors.
Area of Science:
- Bioconjugation Chemistry
- Protein Engineering
- Drug Development
Background:
- Chemoselective ligation technologies allow controlled modification of proteins with polymers.
- These methods incorporate specific anchors into proteins for subsequent polymer attachment.
- This enables precise control over the structure of protein-polymer conjugates.
Purpose of the Study:
- To highlight advances in chemoselective ligation for protein modification.
- To demonstrate the application of these technologies for optimizing drug properties.
- To showcase the development of novel therapeutic agents using this approach.
Main Methods:
- Incorporation of chemoselective anchors into protein backbones (chemical or recombinant).
- Site-specific conjugation of polymers bearing complementary linkers to modified proteins.
- Application of these methods to cytokines and chemokines.
Main Results:
- Achieved site-specific and controlled modification of proteins with polymers.
- Enabled rational optimization of drug efficacy and pharmacokinetic properties.
- Generated new lead proteins for erythropoietic agents and HIV fusion inhibitors.
Conclusions:
- Chemoselective ligation offers a powerful platform for creating well-defined protein-polymer conjugates.
- This technology facilitates the development of improved protein-based therapeutics.
- Applications in erythropoiesis and HIV inhibition demonstrate significant therapeutic potential.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.